Hsien Chun Ng

Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma

H. Huynh, J. Thiery, B. Goh, 2015, Oncotarget.

Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression

E. Domany, T. Tan, J. Thiery, 2019, Nature Communications.

c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression

E. Domany, T. Tan, J. Thiery, 2019, Nature Communications.

MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

H. Huynh, J. Thiery, B. Goh, 2015, Molecular Cancer Therapeutics.

MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma

H. Huynh, J. Thiery, B. Goh, 2015, Molecular Cancer Therapeutics.